Immuron IMRN
NASDAQ IMRN
$1.25 +0.01 (+1.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Immuron (IMRN) Capital Expenditures Growth (1y) (2017 - 2022)

Analysis

Immuron (IMRN) Capital Expenditures Growth (1y) (2017 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Amgen 212.54 Bn 198.55 Bn 7.24 Bn 39.02%
2 Gilead Sciences 186.84 Bn 183.58 Bn 6.22 Bn 30.84%
3 Vertex Pharmaceuticals 129.39 Bn 121.54 Bn 2.84 Bn -22.99%
4 Regeneron Pharmaceuticals 82.05 Bn 74.06 Bn 3.93 Bn 9.68%
5 Moderna 69.00 Bn 63.87 Bn 52.00 Mn 1,133.33%
6 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.67 Bn 29.37 Bn 992.69 Mn 142.64%
8 Biogen 32.37 Bn 31.08 Bn 1.96 Bn 53.76%
9 Roivant Sciences 28.18 Bn 28.87 Bn 1.16 Mn -
10 Immuron 7.25 Mn -1.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 245.61%
Dec 31, 2021 26.80%
Dec 31, 2020 -667.36%
Dec 31, 2017 -218.34%
API Access

Immuron Capital Expenditures Growth (1y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures-growth-1y&ticker=IMRN&period=max&api_key=YOUR_API_KEY